Ionis制药 IONS 深 沪
等待开盘 08-01 09:30:00 美东时间
42.61
-0.760
-1.75%
华盛通- 最 高44.97
- 今 开44.37
- 成交量 266.76万股
- 最 低 42.325
- 昨 收 43.37
- 总市值 67.75亿
- 52周最高 50.43
- 市盈率 静 --
- 换手率 1.68%
- 52周最低 23.95
- 委 比 14.29%
- 总股本 1.59亿
- 历史最高 86.582
- 量 比 1.49
- 振 幅 6.10%
- 历史最低 6.25
- 每 手 1
- 风险率 4.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate
Biogen beat Q2 earnings and revenue estimates, raised full-year EPS guidance, and posted strong gains in Alzheimer's and rare disease drugs.
07-31 23:49
Morgan Stanley Upgrades Ionis Pharmaceuticals to Overweight, Raises Price Target to $62
Morgan Stanley analyst Michael Ulz upgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Equal-Weight to Overweight and raises the price target from $55 to $62.
07-31 19:52
Trump fumes at Powell for not cutting rates, again
President Donald Trump called Jerome Powell "TOO ANGRY, TOO STUPID, & TOO POLITICAL" to have the job of Fed Chair on Thursday, the day after the Federal Open Market Committee held its policy rate at 4...
07-31 19:47
Unisys Announces 2Q25 Results
Unisys delivers strong sequential improvement in both revenue and profitability while taking strategic steps to mitigate U.S. pension volatility Total company revenue of $483.3 million, up 1...
07-31 04:15
Biogen's Earnings Outlook
Biogen (NASDAQ:BIIB) is gearing up to announce its quarterly earnings on Thursd...
07-30 23:01
Ionis Pharmaceuticals shares are trading higher after the company raised FY25 sales guidance above estimates.
Ionis Pharmaceuticals shares are trading higher after the company raised FY25 s...
07-30 19:39
An Overview of Ionis Pharmaceuticals's Earnings
Ionis Pharmaceuticals (NASDAQ:IONS) will release its quarterly earnings report ...
07-30 02:02
KalVista, Biogen, Ionis get EU positive opinions for key drugs
KalVista Pharmaceuticals (NASDAQ:KALV), Biogen (NASDAQ:BIIB), and Ionis Pharmaceuticals (NASDAQ:IONS) announced that the European Medicines Agency (EMA) has given positive endorsements for their produ...
07-25 21:23
Hilton Worldwide Holdings Sees Q3 GAAP EPS $1.89-$1.95 vs $2.08 Est
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURESOUTLOOK: NET INCOME AND DILUTED EPS, ADJUSTED FOR SPECIAL ITEMS(in millions, except per share data)(unaudited) Three
07-23 18:04
